Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Cardiomyocyte loss following myocardial infarction cannot be addressed with current clinical therapies. Cell therapy with induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a potential approach to replace cardiomyocyte loss. However, engraftment rates in pre-clinical studies have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Bui, Thuy Anh, Stafford, Nicholas, Oceandy, Delvac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487209/
https://www.ncbi.nlm.nih.gov/pubmed/37681853
http://dx.doi.org/10.3390/cells12172121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487209/
https://www.ncbi.nlm.nih.gov/pubmed/37681853
http://dx.doi.org/10.3390/cells12172121

Ejemplares similares